With the release of new proposed eligibility rules under the VA Mission Act, we see that privatization at the Veterans Administration (VA) continues to unfold, as outlined in the neoliberal playbook, to which we have alluded before: The stories intertwine because they look like they’re part of the neoliberal privatization playbook, here described in a post about […]
Slow Growth in Medicare and Medicaid Spending Per Enrollee Has Implications for Policy Debates
Since 2006, national health expenditure (NHE) growth has been slow relative to historic growth rates. Annual spending growth between 2006 and 2017 averaged 5.2 percent for Medicare, 6 percent for Medicaid, and 4.4 percent for private health insurance. The Centers for Medicare and Medicaid Services (CMS) project much faster growth in Medicare and Medicaid spending […]
42% of New Cancer Patients Lose Their Life Savings
62 percent of cancer patients report being in debt due to their treatment. 55 percent accrue at least $10,000 in debt, while 3 percent file for bankruptcy. Cancer costs exceed $80 billion in America each year. Rebecca Meyer was diagnosed with glioblastoma when she was 5 years old. She fought bravely for 10 months before […]
Why Is Medicine So Expensive?
The prominence of high drug prices among current American grievances derives from three recent episodes. In 2014 Gilead Sciences brought out Sovaldi, a drug that cures hepatitis C within twelve weeks but costs $1,000 a pill, making the price of a full course of treatment $84,000. In 2015 Turing Pharmaceuticals, a new company headed by […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 65
- Next Page »